By following this strategy, we observed that miRs from G1b (anti-survival) and G2 (anti-survival/EMT) targeted signaling pathways that are associated with the interface between inflammation and tumor initiation/progression, including MAPK, PI3K/AKT and NF-κB pathways (45). Here, AKT1 is linked to neoplasm.